When the global SARS-CoV-2 pandemic hit, most life scientists turned to high-throughput RNA extraction, detection, and sequencing to help stop its spread. Read More

As an industry first, Avida Biomed has fully automated its novel Point-n-Seq® targeted sequencing sample prep as well as targeted methylation enrichment to a <1 day protocol, including only 10-15 minutes of hands-on time, – all achieved on Opentrons’ low cost open-platform liquid handler, the OT-2. Read More